tiprankstipranks
Trending News
More News >
Paradigm Biopharmaceuticals Ltd. (AU:PAR)
ASX:PAR
Australian Market

Paradigm Biopharmaceuticals (PAR) Income Statement

Compare
39 Followers

Paradigm Biopharmaceuticals Income Statement

Last quarter (Q4 2025), Paradigm Biopharmaceuticals's total revenue was AU$35.42K, a decrease of -15.77% from the same quarter last year. In Q4, Paradigm Biopharmaceuticals's net income was AU$-12.85M. See Paradigm Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 52.12KAU$ 65.80KAU$ 46.76KAU$ 79.22KAU$ 20.55K
Gross Profit
AU$ -19.89KAU$ 56.81KAU$ -18.83KAU$ -64.53KAU$ -78.59K
Operating Expenses
AU$ 22.87MAU$ 65.10MAU$ 60.07MAU$ 47.93MAU$ 43.31M
Depreciation and Amortization
AU$ 51.42KAU$ 146.74KAU$ 153.66KAU$ 193.25KAU$ 210.06K
EBITDA
AU$ -25.25MAU$ -64.54MAU$ -59.06MAU$ -46.82MAU$ -42.40M
Operating Income
AU$ -22.89MAU$ -65.19MAU$ -59.22MAU$ -47.01MAU$ -42.34M
Other Income/Expenses
AU$ -2.42MAU$ 6.54MAU$ 263.61KAU$ -1.48KAU$ -302.21K
Pretax Income
AU$ -25.30MAU$ -58.65MAU$ -58.95MAU$ -47.01MAU$ -42.65M
Net Income
AU$ -18.77MAU$ -58.65MAU$ -51.91MAU$ -39.25MAU$ -34.30M
Per Share Metrics
Basic EPS
AU$ -0.06AU$ -0.20AU$ -0.18AU$ -0.16AU$ -0.16
Diluted EPS
AU$ -0.06AU$ -0.20AU$ -0.18AU$ -0.16AU$ -0.16
Weighted Average Shares Outstanding
314.50M 293.28M 289.68M 240.96M 212.19M
Weighted Average Shares Outstanding (Diluted)
314.50M 293.28M 289.68M 241.82M 212.19M
Currency in AUD

Paradigm Biopharmaceuticals Earnings and Revenue History